Gsa Capital Partners LLP Balchem Corp Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$123.38 - $142.72 $723,253 - $836,624	5,862 New	5,862 $727,000
Q1 2021 May 10, 2021	SELL	$107.03 - $131.53 $836,974 - $1.03 Million	-7,820 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$98.58 - $115.22 $447,356 - $522,868	4,538 Added 138.27%	7,820 $901,000
Q3 2020 Nov 06, 2020	BUY	$91.61 - $103.46 $300,664 - $339,555	3,282 New	3,282 $320,000
Q2 2019 Aug 06, 2019	SELL	$90.69 - $102.96 $567,810 - $644,632	-6,261 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$76.21 - $95.45 $269,402 - $337,415	3,535 Added 129.68%	6,261 $581,000
Q4 2018 Feb 12, 2019	BUY	$73.39 - $110.81 $200,061 - $302,068	2,726 New	2,726 $214,000

371

28.5M

267K

5.7K

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.15B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.